Agena Bioscience at ESMO 2016

Activities at the ESMO 2016 Congress

Visit us in Copenhagen to learn how you can combine high sensitivity, accuracy, reliability, and data quality for improved patient management. View our customers' posters, attend our Investigator Studio presentation, stop by booth #205, or schedule a meeting with us directly.

Oral Lecture (Poster)
Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics
  Friday, October 7th: 17:00 - 17:15
  Presenter: Ed Schwalbe, Newcastle University, UK

Investigator Studio
Clinical Rationale for EGFR T790M Testing in Circulating Tumour DNA
  Saturday, October 8th: 16:00 - 16:30
  Kiev lecture room

Speakers:
   Dr. James Sherwood

     Senior Diagnostic Scientist, Personalised Healthcare & Biomarkers, AstraZeneca
   Dr. Darryl Irwin
     Senior Director, Applications Development, Agena Bioscience

Schedule a Meeting
Meet our Executives at ESMO 2016

Scientific Posters

  • Routine molecular subgrouping of medulloblastoma: Bridging the divide between research and the clinic using low-cost, mass spectrometry-based DNA methylomics (Poster #325O)
  • The impact of mass spectrometry multigenic platform on the management of metastatic colorectal patients (Poster #565P)
  • Frequency of driver mutations in EGFR wt NSCLC using mass spectrometry: Experience of Area Vasta Romagna (Poster #1250P)
  • Ultra-sensitive mass spectrometry allows 33% increased detection of somatic EGFR T790M mutation in plasma cfDNA samples (Poster #62P)
  • Implications of key differences across 12 KRAS mutation detection technologies and their relevance in clinical practice (Poster #91P)
  • Identification of breast cancer associated altered DNA methylation in peripheral blood using MALDI-TOF mass spectrometry (Poster #106P)
  • Detection of early genetic and epigenetic alterations in NSCLC by using mass spectrometry and pyrosequencing analysis (Poster #120P)
  • Management optimization of non-small cell lung cancer (NSCLC) specimens. A single institution experience with a multiplexed mass spectrometry approach (Poster #1599P)

Visit us in booth #205